R. Aller

Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.

R. Aller, Daniel Antonio de Luis, Olatz Izaola et al. · PubMed · 2011 · 373 citations

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

Ramy Younes, Olivier Govaere, Salvatore Petta et al. · Gut · 2021 · 191 citations · Full text

Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease

Ramy Younes, Gian Paolo Caviglia, Olivier Govaere et al. · Journal of Hepatology · 2021 · 178 citations · Full text

Obesity, Metabolic Syndrome, Hepatology +12

Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

Javier Ampuero, Raluca Pais, R. Aller et al. · Clinical Gastroenterology and Hepatology · 2019 · 174 citations · Full text

Metabolic Associated Steatohepatitis, Hepatology, Metabolic Associated Steatotic Liver Disease +13

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

Timothy Hardy, Kristy Wonders, Ramy Younes et al. · Contemporary Clinical Trials · 2020 · 128 citations · Full text